Tag: Immunotherapy

Analysis of pooled data from proof-of-concept trials shows bnAb VRC01 does reduce incidence of infection with VRC01-sensitive isolates

Ratio of IL-10/TNFα produced by T1B three months after renal transplantation predicts clinical, subclinical rejection during first year

FMT plus anti-PD-1 therapy may change gut microbiome and help overcome drug resistance in some patients with advanced melanoma

Less than 1 percent of patients receiving antitumor treatment between Jan. 15 and May 4, 2020, developed COVID-19

Majority of children reach tolerance great enough to protect them from accidental exposure to peanuts

Mutation frequencies of EGFR and KRAS were 30 and 10 percent, respectively, and 23 and 13 percent, respectively, for Mexican and Colombian patients

Phase 2 study reveals high objective response rate for CAR T-cell therapy in patients with follicular lymphoma, marginal zone lymphoma

Guidance focuses on tailored treatment interventions for specific age groups based on disease severity

Findings seen in preclinical studies of mice, survival data from patients receiving PD-(L)1 blockade for GBM

Histology slides, clinical data used to predict immune checkpoint inhibitor response in advanced melanoma